Immunocore Holdings plc IMCR

Rank #2244 · Nasdaq · $1.6B market cap

Audited by Deloitte LLP, no going-concern flag in the latest filing.

Score

27.5

P/E

-28.1

P/B

4.58

ROE

-16.3%

Op. Margin

-23.9%

Debt Ratio

191%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Weak

P/E -28.1x, P/B 4.58x. Ranks in the top 70% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -16.3%. Ranks in the top 81% of the universe.

Safety ★★☆☆☆

Weak

Debt ratio 191%. Ranks in the top 61% of the universe.

Growth ★★★★★

Excellent

Revenue growth of 43.1% year over year. Ranks in the top 8% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2023	$0.0B	$-0.2B	$-0.2B	$0.1B	-478.5	244
2024	$0.2B	$-0.1B	$-0.1B	$0.2B	-29.7	98
2025	$0.2B	$-0.1B	$-0.1B	$0.3B	-23.9	191